Abstract
Recent advances in perioperative management of adult and pediatric patients requiring open heart surgery (OHS) and cardiopulmonary bypass (CPB) for cardiac and/or congenital heart diseases repair allowed a significant reduction in the mortality rate. Conversely morbidity rate pattern has a flat trend. Perioperative period is crucial since OHS and CPB are widely accepted as a deliberate hypoxic-ischemic reperfusion damage representing the cost to pay at a time when standard of care monitoring procedures can be silent or unavailable. In this respect, the measurement of neuro-biomarkers (NB), able to detect at early stage perioperative brain damage could be especially useful. In the last decade, among a series of NB, S100B protein has been investigated. After the first promising results, supporting the usefulness of the protein as predictor of short/long term adverse neurological outcome, the protein has been progressively abandoned due to a series of limitations. In the present review we offer an up-dated overview of the main S100B pros and cons in the peri-operative monitoring of adult and pediatric patients.
Original language | English |
---|---|
Pages (from-to) | 317-331 |
Number of pages | 15 |
Journal | Clinical Chemistry and Laboratory Medicine |
Volume | 60 |
Issue number | 3 |
Early online date | 11 Jan 2022 |
DOIs | |
Publication status | Published - 23 Feb 2022 |
Keywords
- brain injury
- cardiac surgery
- cardiopulmonary bypass
- neurobiomarker
- neuromonitoring
- S100B
- OPEN-HEART-SURGERY
- HYPOTHERMIC CIRCULATORY ARREST
- CEREBRAL OXYGEN-SATURATION
- CARDIOPULMONARY BYPASS
- INFLAMMATORY RESPONSE
- REOXYGENATION INJURY
- S-100 PROTEIN
- BIOCHEMICAL MARKERS
- CEREBROSPINAL-FLUID
- NEUROLOGIC INJURY